Abstract
Our access to highly efficient drugs against hyperlipoproteinemia (1,2) and to a high resolution femoral angiography technique (3) prompted us to study the effect of pronounced serum-lipid lowering on the development of femoral atherosclerosis in hyperlipoproteinemia.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Olsson AG, Walldius G, Wahlberg G (1986) Pharmacological control of hyperlipidaemia: Nicotinic acid and its analogues — mechanisms of action, effects and clinical usage. In: Fears R (ed) Pharmacological Control of Hyperlipidaemia. J Prous Science Publishers, pp. 217–230.
Rössner S, Olsson AG (1980) Effects of combined procetofene-nicotinic acid therapy in treatment of hypertriglyceridaemia. Atherosclerosis 35:413–417.
Ruhn G, Erikson U, Helmius G, Hemmingsson A (1982) Computerized quantitation of atherosclerosis in an experimental model. Acta Radiol (Diagn) 23:621–625.
Olsson AG, Erikson U, Helmius G, Hemmingsson A, Ruhn G (1984) Regression of femoral atherosclerosis in humans: Methodological and clinical problems associated with studies on femoral atherosclerosis development as assessed by angiograms. In: Manilow MR, Blaton VH (eds) Regression of Atherosclerotic Lesions: Experimental Studies and Observations in Humans. New York: Plenum Press, pp. 311–328.
Erikson U, Helmius G, Hemmingsson A, Olsson AG, Ruhn G Arteriography of patients included in a regression study. Workshop on the Evolution of the Human Atherosclerotic Plaque. Rockville, Maryland, September 1986.
Beaumont JL, Carlson LA, Cooper GR, Fejfar Z, Fredrickson DS, Strasser T (1970) Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull WHO 43:891.
Carlson K (1973) Lipoprotein fractionation. J Clin Path 26 Suppl (Ass Clin Path) 5:32–37.
Zlatkis A, Zak B, Boyle AJ (1953) A new method for the direct determination of serum cholesterol. J Lab Clin Med 41:486–492.
Fletcher MJ (1968) A colorimetric method for estimating serum triglycerides. Clin Chim Acta 22:393–397.
Kelsey S Problems and strategies for statistical analysis of angiographic data: Issue of changes in individual lesion versus individual patients. Workshop on the Evolution of the Human Atherosclerotic Plaque. Rockville, Maryland, September 1986.
Barndt R, Blankenhorn DH, Crawford DW, Brooks SH (1977) Regression and progression of early femoral atherosclerosis in treated hyperlipoproteinemia patients. Annals of Internal Medicine 86:139–146.
Little JA, Kakis G, Feather T, Breckenridge CW (1985) Plasma high density lipoprotein triglyceride (HDL-TG) as a risk factor for ischemic vascular disease in a prospective study. Proceedings of Poster Communications, 7th International Symposium on Atherosclerosis, Melbourne October 1969.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag New York Inc.
About this paper
Cite this paper
Olsson, A.G., Erikson, U., Helmius, G., Hemmingsson, A., Holme, I., Ruhn, G. (1990). Femoral Lesion Change in Relation to Measured Risk Factors in the Stockholm-Uppsala Trial. In: Glagov, S., Newman, W.P., Schaffer, S.A. (eds) Pathobiology of the Human Atherosclerotic Plaque. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3326-8_42
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3326-8_42
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7968-6
Online ISBN: 978-1-4612-3326-8
eBook Packages: Springer Book Archive